Disease Detection news and technical articles from BioOptics World. Search Disease Detection latest and archived news and articles
NanoSight (Amesbury, England) to quickly size and phenotype cellular vesicles for use as biomarkers for early disease detection . Their findings overcome previous limitations in the technology available for their measurement. The NTA system
sensitive biosensor capable of identifying the smallest single virus particles in solution, which could advance early disease detection at the point-of-care and cut waiting for test results from weeks to minutes.
A fiber laser able to produce 25 times more light than other lasers operating at a similar wavelength has proven able to detect very low concentrations of gases.
Recent advances in optics and electronics could make cytometric technology highly affordable and broadly applicable within the next few years, filling new niches and challenging the traditional dominance of flow cytometry in some older ones.
A new optical coherence tomography (OCT) device about the size of a handheld video camera could enable primary care physicians to detect retinal diseases -- including diabetic retinopathy, glaucoma, and macular degeneration -- in their early stages to improve treatment outcomes
A biosensor able to identify the smallest single virus particles (each just 6 attograms) hopes to revolutionize early disease diagnosis by providing results within minutes at the point of care.
Fast or accurate? Those are typically your choices for flu diagnosis. But a new biophotonics approach offers both speed and accuracy, and low cost as well—all things that are supremely helpful during outbreaks, especially because antiviral drugs are most effective in the early stages of disease.
biomarkers need to be present compared to a conventional immunoassay. The development opens new opportunities for early disease detection and treatment—and perhaps equally important, it requires no changes for researchers and technicians: The new
[BLANK_AUDIO] Bio markers are key to diagnosing diseases. The, perhaps the most famous example of this is glucose for the diabetic patient, but bio markers are like a key to a door and behind this door we don't know whether or not we're healthy or diseased. But with that biomarker information we
Stratophase has wrapped up its Portable Direct Immunoassay Diagnosis Devices for Animals and Humans project, which assessed the feasibility of using a self-contained, portable detection unit that uses proprietary optical microchip technology to accurately identify the presence of foot and mouth ...